Clinical trial
Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal…
NCT00003360 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003360 |
|---|---|
| Title | Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal Cancer |
| Official title | Phase I Study of 131I-Labeled Humanized Antibody A33 in Patients With Advanced Colorectal Carcinoma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Radiation |
| Interventions | iodine I 131 monoclonal antibody A33 |
| Enrollment | 24 |
| Start date | Apr 1, 1998 |
| Primary completion | Aug 1, 2000 |
| First posted | Aug 16, 2004 |
| Last update posted | Jan 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: